A Randomized Placebo Controlled Clinical Trial to Determine the Impact of Digestion Resistant Starch MSPrebiotic(®) on Glucose, Insulin, and Insulin Resistance in Elderly and Mid-Age Adults

INTRODUCTION: Type 2 diabetes (T2D) has reached epidemic proportions in North America. Recent evidence suggests that prebiotics can modulate the gut microbiome, which then plays an important role in regulating lipid metabolism, blood glucose, and insulin sensitivity. As such, prebiotics are appealin...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfa, Michelle J., Strang, David, Tappia, Paramjit S., Olson, Nancy, DeGagne, Pat, Bray, David, Murray, Brenda-Lee, Hiebert, Brett
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787146/
https://www.ncbi.nlm.nih.gov/pubmed/29410955
http://dx.doi.org/10.3389/fmed.2017.00260

Ejemplares similares

Ejemplares similares